Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Phase 3 trials extended to 68 weeks confirmed continued weight loss (28.7% at 68 weeks vs 24.2% at 48 weeks on the 12mg dose)
"Individuals with type 1 can work with their medical teams to determine whether GLP-1 receptor agonists may be beneficial for obesity treatment or glycemic management," Van Name said
Which brand or formulation is preferred
Can childhood vitiligo improve
Lower cost enables longer treatment duration, which matters because tirzepatide works best with sustained use over 12 to 18 months
US$ 24.91
US$ 26.06
US$ 29.95
US$ 22.75
US$ 27.85
US$ 27.02
